JP2001504799A5 - - Google Patents

Download PDF

Info

Publication number: JP2001504799A5
Authority: JP; Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

JP1997532759A

Other languages

English (en)

Other versions

JP2001504799A (ja

Filing date

1997-03-10

Publication date

2004-12-02

1997-03-10 Application filed filed Critical

1997-03-10 Priority claimed from PCT/US1997/003778 external-priority patent/WO1997033602A1/en

2001-04-10 Publication of JP2001504799A publication Critical patent/JP2001504799A/ja

2004-12-02 Publication of JP2001504799A5 publication Critical patent/JP2001504799A5/ja

Status Withdrawn legal-status Critical Current

Description

JP53275997A 1996-03-11 1997-03-10 Ｈｌａ分子への結合アフィニティーが増加したペプチド Withdrawn JP2001504799A (ja)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US1311396P	1996-03-11	1996-03-11
US60/013,113		1996-03-11
PCT/US1997/003778 WO1997033602A1 (en)	1996-03-11	1997-03-10	Peptides with increased binding affinity for hla molecules

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2008327605A Division JP2009108097A (ja)	1996-03-11	2008-12-24	Ｈｌａ分子への結合アフィニティーが増加したペプチド

Publications (2)

Publication Number	Publication Date
JP2001504799A JP2001504799A (ja)	2001-04-10
JP2001504799A5 true JP2001504799A5 (ja)	2004-12-02

Family

ID=21758378

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
JP53275997A Withdrawn JP2001504799A (ja)	1996-03-11	1997-03-10	Ｈｌａ分子への結合アフィニティーが増加したペプチド
JP2008327605A Pending JP2009108097A (ja)	1996-03-11	2008-12-24	Ｈｌａ分子への結合アフィニティーが増加したペプチド

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
JP2008327605A Pending JP2009108097A (ja)	1996-03-11	2008-12-24	Ｈｌａ分子への結合アフィニティーが増加したペプチド

Country Status (9)

Country	Link
EP (1)	EP0914142B9 (ja)
JP (2)	JP2001504799A (ja)
CN (1)	CN1225590A (ja)
AT (1)	ATE511849T1 (ja)
AU (1)	AU2203797A (ja)
BR (1)	BR9708161A (ja)
CA (1)	CA2248657A1 (ja)
ES (1)	ES2367640T3 (ja)
WO (1)	WO1997033602A1 (ja)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9340577B2 (en)	1992-08-07	2016-05-17	Epimmune Inc.	HLA binding motifs and peptides and their uses
US6183746B1 (en)	1997-10-09	2001-02-06	Zycos Inc.	Immunogenic peptides from the HPV E7 protein
US6013258A (en) *	1997-10-09	2000-01-11	Zycos Inc.	Immunogenic peptides from the HPV E7 protein
CA2323632A1 (en) *	1998-03-13	1999-09-16	Epimmune Inc.	Hla-binding peptides and their uses
AU3215800A (en) *	1999-01-27	2000-08-18	Epimmune, Inc.	Identification of broadly reactive hla restricted t cell epitopes
US7361338B2 (en)	1999-10-05	2008-04-22	Agensys, Inc.	Methods to inhibit growth of prostate cancer cells
EP1230268B1 (en) *	1999-11-18	2009-10-14	Pharmexa Inc.	Heteroclitic analogs of class i epitopes
US7462354B2 (en)	1999-12-28	2008-12-09	Pharmexa Inc.	Method and system for optimizing minigenes and peptides encoded thereby
ES2323407T3 (es)	2000-07-12	2009-07-15	Agensys, Inc.	Nuevo antigeno tumoral util en el diagnostico y terapia del cancer de vejiga, ovario, pulmon y riñon.
AU8846601A (en)	2000-08-28	2002-03-13	Agensys Inc	Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer
AU2002246708A1 (en) *	2000-12-15	2002-08-12	Agensys, Inc.	Nucleic acid and encoded zinc transporter protein entitled 108p5h8 useful in treatment and detection of cancer
US6924358B2 (en)	2001-03-05	2005-08-02	Agensys, Inc.	121P1F1: a tissue specific protein highly expressed in various cancers
US7271240B2 (en)	2001-03-14	2007-09-18	Agensys, Inc.	125P5C8: a tissue specific protein highly expressed in various cancers
WO2002083921A2 (en)	2001-04-10	2002-10-24	Agensys, Inc.	Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
US20030191073A1 (en)	2001-11-07	2003-10-09	Challita-Eid Pia M.	Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
CA2447564A1 (en) *	2001-05-15	2002-11-21	Agensys, Inc.	Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
WO2002094994A2 (en)	2001-05-18	2002-11-28	Mayo Foundation For Medical Education And Research	Chimeric antigen-specific t cell-activating polypeptides
US20060222656A1 (en)	2005-04-01	2006-10-05	University Of Maryland, Baltimore	MAGE-A3/HPV 16 peptide vaccines for head and neck cancer
JP2005505271A (ja)	2001-09-06	2005-02-24	アジェンシス，インコーポレイテッド	癌の処置および検出において有用なｓｔｅａｐ−１と名称が与えられる核酸および対応するタンパク質
US20060018915A1 (en) *	2002-04-05	2006-01-26	Glenn Ishioka	Heteroclitic analogs and related methods
US20040101534A1 (en) *	2002-06-25	2004-05-27	Diamond Don J.	Adjuvant-free peptide vaccine
AU2003243151A1 (en)	2002-08-16	2004-03-03	Agensys, Inc.	Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
EP1565200A4 (en)	2002-11-27	2009-06-24	Agensys Inc	NUCLEIC ACID 24P4C12 AND CORRESPONDING PROTEIN FOR THE TREATMENT AND DETECTION OF CANCER
EP2343315A3 (en)	2003-02-10	2011-11-23	Agensys, Inc.	Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
ES2384622T3 (es)	2003-05-30	2012-07-10	Agensys, Inc.	Variantes del antígeno de células madre de próstata (PSCA) y subsecuencias de las mismas
EP1753871B1 (en)	2004-05-28	2015-07-15	Agensys, Inc.	Antibodies and related molecules that bind to psca proteins
CA2603093A1 (en)	2005-03-31	2006-10-05	Agensys, Inc.	Antibodies and related molecules that bind to 161p2f10b proteins
JP5133706B2 (ja) *	2006-01-23	2013-01-30	株式会社グリーンペプタイド	Ｃ型肝炎ウイルス由来ペプチド
EP1982992B1 (en) *	2006-02-07	2010-10-27	NEC Corporation	Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector
WO2008044567A1 (fr)	2006-10-12	2008-04-17	Nec Corporation	Peptide liant les molécules hla, son précurseur, fragment d'adn le codant et vecteur recombinant
EP3085707B1 (en)	2007-11-01	2019-02-27	Mayo Foundation for Medical Education and Research	Hla-dr binding peptides and their uses
JP5792630B2 (ja) *	2009-01-28	2015-10-14	エピミューン，インコーポレイティド	Ｐａｎ−ｄｒ結合ポリペプチドおよびその使用
AU2012258603A1 (en) *	2011-05-26	2014-01-16	Geneius Biotechnology, Inc.	Modulated immunodominance therapy
CN110651189A (zh)	2017-03-03	2020-01-03	特雷斯生物公司	肽疫苗
MX2021002449A (es)	2018-09-04	2021-08-05	Treos Bio Ltd	Vacunas peptidicas.
US11161892B1 (en)	2020-12-07	2021-11-02	Think Therapeutics, Inc.	Method of compact peptide vaccines using residue optimization
US11058751B1 (en)	2020-11-20	2021-07-13	Think Therapeutics, Inc.	Compositions for optimized RAS peptide vaccines
US11421015B2 (en)	2020-12-07	2022-08-23	Think Therapeutics, Inc.	Method of compact peptide vaccines using residue optimization
US11464842B1 (en)	2021-04-28	2022-10-11	Think Therapeutics, Inc.	Compositions and method for optimized peptide vaccines using residue optimization

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5200320A (en) *	1987-12-07	1993-04-06	National Jewish Center For Immunology And Respiratory Medicine	Method for identifying useful polypeptide vaccines
ATE342730T1 (de) *	1992-08-07	2006-11-15	Pharmexa Inc	Hla bindepeptide und ihre verwendungen
US20050271676A1 (en) *	1993-03-05	2005-12-08	Epimmune Inc.	Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions
ATE227118T1 (de) *	1993-08-02	2002-11-15	Scripps Research Inst	Peptide zum induzieren einer antwort der zytotoxischen t-lymphozythen gerichetetgegen das hepatitis b-virus
AU685521B2 (en) *	1993-10-19	1998-01-22	Ajinomoto Co., Inc.	Peptide capable of inducing immune response against HIV and aids preventive or remedy containing the peptide

1997
- 1997-03-10 AT AT97914975T patent/ATE511849T1/de not_active IP Right Cessation
- 1997-03-10 CA CA002248657A patent/CA2248657A1/en not_active Abandoned
- 1997-03-10 ES ES97914975T patent/ES2367640T3/es not_active Expired - Lifetime
- 1997-03-10 EP EP97914975A patent/EP0914142B9/en not_active Expired - Lifetime
- 1997-03-10 CN CN97194430A patent/CN1225590A/zh active Pending
- 1997-03-10 JP JP53275997A patent/JP2001504799A/ja not_active Withdrawn
- 1997-03-10 WO PCT/US1997/003778 patent/WO1997033602A1/en active Application Filing
- 1997-03-10 AU AU22037/97A patent/AU2203797A/en not_active Abandoned
- 1997-03-10 BR BR9708161A patent/BR9708161A/pt not_active IP Right Cessation
2008
- 2008-12-24 JP JP2008327605A patent/JP2009108097A/ja active Pending

Publication	Publication Date	Title
JP2000502280A5 (ja)	2005-06-16
JP2001505081A5 (ja)	2005-03-10
JP2001510326A5 (ja)	2005-02-10
JP2000501771A5 (ja)	2004-08-19
JP2000501599A5 (ja)	2005-05-12
JP2000501018A5 (ja)	2005-05-12
JP2000505690A5 (ja)	2005-07-14
JP2001527704A5 (ja)	2004-12-09
JP2000501324A5 (ja)	2005-05-12
JP2000501338A5 (ja)	2005-05-12
JP2000501825A5 (ja)	2005-04-07
JP2001505463A5 (ja)	2005-08-11
JP2000500874A5 (ja)	2005-04-07
JP2000501774A5 (ja)	2005-04-07
JP2000502570A5 (ja)	2004-11-18
JP2000502568A5 (ja)	2004-11-11
JP2000500912A5 (ja)	2005-02-10
JP2001504799A5 (ja)	2004-12-02
JP2000501744A5 (ja)	2004-11-11
JP2000505733A5 (ja)	2005-09-08
JP2000500857A5 (ja)	2005-03-10
JP2000502714A5 (ja)	2004-11-11
JP2000501229A5 (ja)	2005-04-07
JP2000500318A5 (ja)	2005-04-07
JP2000501569A5 (ja)	2005-05-12